Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Mississippi for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Mississippi only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Mississippi (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

John Hrom (NPI 1134238496)

Field	Value
Entity Type	Individual
Organization	John Hrom
Address	301 S 28th Ave
City	Hattiesburg
State	MS
ZIP	39401
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	August 30, 2006

Payer Source	Total Paid
Medicare	$1.6M
Medicaid	$0

Key Findings

This profile is overwhelmingly infusion- and drug-centric: the single largest line-item is J9271 (pembrolizumab) with 17.2K claims and $739.6K revenue (46.9% of the provider's Medicare revenue), supported by J0897 (denosumab) at $219.2K (13.9%) and Q5115 (rituximab-abbs) at $151.6K (9.6%). Those three immunotherapy/biologic injection codes together account for 70.5% of this provider's total Medicare revenue, indicating the practice operates primarily as an oncology infusion service rather than a visit-driven primary care clinic.

Medicare is the sole payer of scale for this NPI: lifetime Medicare revenue is $1.6M while there is no Medicaid billing on file. This makes the provider effectively single-payer (Medicare) at present, concentrating reimbursement and risk exposure in that program rather than in state Medicaid.

The provider shows a concentrated revenue base driven by high-cost injectable therapies rather than E&M services: office visit code 99214 generated $91.4K (1K claims, $88 avg) and 99213 generated $32.1K (563 claims, $57 avg), both substantially smaller than the pembrolizumab line. This mix implies clinical capacity and revenue depend primarily on drug administration and infusion throughput instead of routine outpatient evaluation and management.

Competitive standing by code is mixed: J9271 (pembrolizumab) is a typical, unremarkable volume position nationally (ranks #541 of 1841; 70th percentile), while J0897 (denosumab) ranks #812 of 10057 (92th percentile; typical, unremarkable volume) and Q5115 (rituximab-abbs) is relatively concentrated versus peers (ranks #11 of 79; 87th percentile; typical, unremarkable volume). At the same time, several administration codes are extreme outliers versus national peers — for example 96413 (chemotherapy infusion) is an extreme outlier at the 99th percentile (ranks #44 of 7514) — signaling above-typical chemotherapy administration intensity compared with national peers.

Multiple infusion- and administration-related codes are flagged as unusually high-volume relative to peers: 96375 is a 99th percentile extreme outlier (ranks #35 of 5191), J2469 is a 100th percentile extreme outlier (ranks #7 of 2634), and J9201 is a 100th percentile extreme outlier (ranks #4 of 631). These statistical flags, together with the high share of revenue from drug codes, suggest operational emphasis on repeated infusion sessions and a practice workflow optimized for injectable oncology therapies.

The provider has long tenure: the NPI was enumerated 2006-08-30 (~20 years ago), indicating an established practice presence in HATTIESBURG, MS. That longevity plus the infusion-heavy code mix may reflect a stable, specialized service line focused on oncology medications and supportive infusions rather than recent or transient activity.

There are large disparities between claim counts and per-claim payments for some items that affect revenue composition: J1439 shows 55.5K claims at $1 avg paid/claim for $55.5K revenue, and J2469 shows 5.5K claims at $1 avg paid/claim for $5.5K revenue. These patterns indicate very high claim volume for low-dollar items while most dollars are concentrated in a few high-cost biologic injections, which has implications for utilization monitoring and operational throughput metrics.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

49 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	17,200	$40	$739.6K
J0897	Injection, denosumab, 1 mg	12,180	$20	$219.2K
Q5115	Injection, rituximab-abbs, biosimilar, (truxima), 10 mg	4,210	$40	$151.6K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	1,140	$90	$101.3K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,040	$90	$91.4K
J1439	Injection, ferric carboxymaltose, 1 mg	55,500	$1	$55.5K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	560	$60	$32.1K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	520	$50	$25.4K
96375	Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the…	1,990	$10	$21.9K
85025	A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a…	2,480	$10	$19.8K

Showing 1–10 of 49

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 49 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Mississippi Distribution

John Hrom — 9 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Mississippi

Full comparison — all codes billed, vs. state median

49 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	6	10	16,700	$40	$1M
Q5115	1	10	4,210	$40	$151.8K
J0897	14	110	3,030	$20	$95.7K
J1439	6	20	42,000	$1	$41.6K
96413	3	70	100	$80	$22.6K
99214	212	4,110	170	$70	$21.9K
J3490	1	20	90	$150	$17.8K
99232	1,041	1,490	100	$60	$12.9K
99213	308	4,000	100	$50	$10.3K
99215	801	900	40	$110	$9K

Showing 1–10 of 49

Related Providers

Other providers that share a Tax Identification Number (TIN) with John Hrom, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Hattiesburg Clinic PA	MS	Multi-Specialty Clinic/Center	$0	$59.5M
Hattiesburg Clinic PA	MS	Pediatrics Physician	$0	$10.9M
Hattiesburg Clinic PA	MS	Pediatrics Physician	$0	$7.9M
State Of Mississippi - University Of Mississippi Medical Center	MS	Critical Access Hospital	$0	$7.5M
Hattiesburg Clinic PA	MS	Ambulatory Surgical Clinic/Center	$4.5M	$2.4M
Lowery A. Woodall Outpatient Surgery Facility, LLC	MS	Ambulatory Surgical Clinic/Center	$446.4K	$6.1M
Hattiesburg Clinic PA	MS	Clinical Medical Laboratory	$2.2M	$3.3M
Hattiesburg Clinic, PA	MS	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$5.3M
Imad Bitar	MS	Rheumatology Physician	$3M	$0
Hattiesburg Clinic PA	MS	Obstetrics & Gynecology Physician	$0	$2.8M

Nearby Providers

Other providers in the same ZIP code as John Hrom, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Region 12 Commission On Mental Health & Retardation Pine Belt Men	MS	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$108.3M
Forrest County General Hospital	MS	General Acute Care Hospital	$0	$81.6M
Doves Home Care	MS	Home Health Agency	$0	$12M
Neighborhood Healthcare Providers	MS	Internal Medicine Physician	$0	$10.9M
Top Choice Healthcare	MS	In Home Supportive Care Agency	$0	$6M
Relias Emergency Medicine Specialists Of Hattiesburg LLC	MS	Emergency Medicine Physician	$0	$5M
Southern Surgery Center, LLC	MS	Ambulatory Surgical Clinic/Center	$4.7M	$103.6K
South Mississippi Emergency Physicians PA	MS	Emergency Medicine Physician	$0	$3.2M
Southern Mississippi Neonatology, PA	MS	Neonatal-Perinatal Medicine Physician	$0	$2.7M
Minor Care Clinic	MS	Federally Qualified Health Center (FQHC)	$0	$2.5M

John Hrom — Billing Profile & Reimbursement Data

Sign up for John Hrom — Billing Profile & Reimbursement Data policy alerts

John Hrom — Billing Profile & Reimbursement Data

Sign up for John Hrom — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References